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Summary 
Mutations within the class I major histocompatibility  complex (MHC) molecule that affect a 
peptide binding can result in strong allogeneic responses. It is believed  this reflects, in part, binding 
of a different  set  of endogenous peptides  by each MHC  molecule.  We have examined  the 
representation of allopeptides recognized by Kb-specific cytotoxic T lymphocytes (CTL) clones 
among  targets  that  express either  the  K  b or  the  K  bin8 mutant.  These  class  I  molecules 
mutationally differ by several residues at the base of the peptide binding groove resulting in lack 
of recognition of bm8 targets by most Kb-specific CTL, and in strong mutual alloreactivity. 
Since these differences  involve pockets in the base of the peptide binding groove that are presumed 
to contribute to the affinity of peptide binding, and there is evidence for differences in peptide 
binding by the mutant and wild type molecule, it was considered most likely that alloreactivity 
was due to binding of different sets of peptides by each of these molecules. Surprisingly, the 
allopeptides recognized by Kb-specific clones from a variety of responders, including bin8,  are 
often found associated with both the wild type and mutant class I molecules. Although for some 
allopeptides the amount of peptide normally found associated with bm8 is less than that associated 
with K  b, reactivity could not be restored by increasing the amount of the relevant peptide. Thus, 
the basis for much of the aUoreactivity  observed  in this particular mutant and wild type combination 
is not the presence or absence of the relevant allopeptide but rather the different conformation 
adapted by the peptide-MHC complex. These results allow us to conclude that strong alloreactive 
responses can result from T cell recognition of  conformational differences  between the stimulation 
and responder  MHC molecules. 
M 
HC class I molecules bind short peptide ligands repre- 
sentative of endogenously synthesized cellular proteins 
(1, 2). Formation of a stable MHC-peptide complex usually 
requires that the peptide sequence  contain an appropriate motif 
that provides complementarity with the peptide binding deft 
of the MHC molecule at certain key anchor positions (3-9). 
However, this constraint is sufficiently unrestrictive such that 
100's-l,000's  of different peptide sequences are able to bind 
each allelic form of MHC (10, 11). 
It is believed that the T cell receptor interacts with the 
upper surfaces of the MHC ol-helices and accessible  portions 
of bound peptide (12). The high frequency of alloreactive T 
cells is the result of the large number of antigenic MHC-pep- 
tide complexes  that are available for recognition (13-16). How- 
ever, the basis for antigenicity of each of the various com- 
plexes may differ. Although allogeneic differences on class 
I that involve residues that interact directly with the TCR 
can be immunogenic (17), most allelic  variation involves MHC 
residues that interact with the peptide rather than TCR (18). 
A sequence difference between the responder and the stimu- 
lator within the antigen binding groove could result in binding 
of a different set of peptides by each class I molecule, thereby 
leading to reciprocal antigenicity.  It is also possible that a 
qualitative difference in peptide expression could lead to an- 
tigenicity. For example, if we consider that self-tolerance of 
a particular self-peptide-MHC complex only eliminates dones 
bearing  TCRs with high affinity, it is possible that by in- 
creasing the number of these same peptide-MHC complexes, 
some T cells whose receptor affinity was sufficiently low to 
avoid deletion during thymic development may now be stimu- 
lated. Alternatively, MHC molecules that differ in their pep- 
tide binding grooves may bind the same peptide yet could 
differ with respect to the conformation of the MHC-pep- 
tide complex. In a recent report involving recognition of an 
ovalbumin peptide, it was found that a change in a peptide 
pointing into the peptide binding groove abolished T  cell 
recognition, presumably by altering the conformation of the 
complex (19). It is possible that a change in the base of the 
213  j. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/94/01/0213/07  $2.00 
Volume 179  January  1994  213-219 peptide binding groove of class I could similarly result in a 
conformational change in the complex that results in antige- 
nicity. 
Most alloreactive responses involve MHC differences that 
potentially effect both the o~-helices  and peptide binding groove 
of the MHC. To evaluate the relative contribution to an al- 
logeneic response of the possibilities considered above that 
relate to peptide binding, we have investigated the basis for 
allorecognition between two murine strains that mutation- 
ally differ from one another at residues at  the base of the 
peptide binding groove (20).  The sequence differences be- 
tween  K b and  the  K bins mutant  are  confined to  residues 
22-24 and 30,  all of which are at  the base of the peptide 
binding groove. Based on the x-ray crystal structure of K b 
(7-9), both 22 and 24 are involved in formation of pockets 
that accommodate peptide residues, thereby contributing to 
the affinity of interaction. As anticipated for a mutation that 
effects peptide binding, the majority of Kb-specific CTL do 
not recognize the bm8 molecule. Also, these strains demon- 
strate a strong reciprocal allogeneic response. Analysis of the 
contribution of individual residues that differ between K b 
and  the  K bm8 mutant  to  allorecognition (21)  and peptide 
binding (22) have concluded that residue 24 is dominant in 
determining the bm8 phenotype. 
Despite these differences, our results indicate that peptides 
recognized by Kb-specific CTL are often present in both the 
mutant and wild type molecule. This suggests that the basis 
for differences in CTL recognition of these particular class 
I molecules is often not the presence or absence of a partic- 
ular  allopeptide, but  rather the conformation of the pep- 
tide-MHC  complex. 
after which beads were removed and washed three times before 
resuspension in 2 ml 0.2% trifluoroacetic  acid. Beads  were discarded, 
and the eluate passed through a Centricon-10 (Amicon, Beverly, 
MA) filter to remove high molecular weight material, lyophilized, 
and resuspended in I ml distilled water (or the indicated volume). 
A synthetic peptide (GYVYQGLKSGN) representing the epitope 
recognized by VSV-N-specific CTL was kindly provided by Dr. 
Nancy Hosken. Derivation of HPLC purified allopeptide recog- 
nized by bm8.28 represents fraction 31 in the Y3 purified K  b pep- 
tide from EL4 described in reference 25. 
Cytotoxicity Assays.  The indicated amount of peptide was in- 
cubated with 51Cr-labeled target cells for 30 min in a volume of 
100/zl RPMI  1640 before addition of the indicated number of 
effector cells in media containing  10% FCS. Cytotoxicity assays 
were  performed  as  previously described unless otherwise  spe- 
cified (16). 
Results 
As previously reported, and demonstrated in Table 1, the 
majority of CTL clones  specific  for K b do  not  recognize 
bm8 targets (27). Also, a vigorous CTL response is obtained 
when bm8 T  cells are stimulated with K b stimulators (28). 
The simplest explanation for such allorecognition would be 
that  not  all  peptides capable of binding K b also  bind  the 
bm8 mutant; therefore bm8 mice would not be tolerant of 
these Kb-peptide complexes. If this were the case,  then a 
pool  of peptides  extracted  from  K b but  not  from  bm8 
should  contain  peptides  required  for  recognition by  K b- 
specific CTL clones. 
To test this hypothesis, peptides were extracted from ei- 
Materials  and  Methods 
Mice.  C57BL/6 and  B6.-H-2 bms mice used in  these studies 
were obtained from the breeding colony of The Scripps Research 
Institute. 
Cell Lines.  Kb-specific CTL clones and T2-K  b cells used as 
targets are as previously described (16). The VSV-N-specific CTL 
line used in these studies was obtained from Dr. Nancy Hosken  Clone 
and Dr. Michael Bevan (Howard Hughes Medical Institute, Univer- 
sity of Washington,  Seattle, WA) (23). T2-K  bins targets were pre-  bmS. 10 
pared by transfection of T2 cells with a mixture of pSVneo DNA 
(2/zg) and 10 #g of plasmid DNA containing  the K  bms cDNA 
gene obtained from Dr. Per Peterson of this institute. Transfection  bm8.28 
was performed as previously described using a Gene Pulser [230 
mV; 960 mfd; Bio-Rad Laboratories, Richmond, CA; (24)]. Cells 
were immediately cloned in media containing G418 at 800/zg/ml  72 
(effective  concentration). The clone used in these studies expresses 
threefold less K  bms than the amount of K  b expressed on T2-K  b cells 
as determined by FACS  |  analysis (Becton Dickinson & Co., Moun-  m6 
tain View, CA) using  the Kb-speciflc monoclonal  antibody, Y3 
(25). 
Peptides.  Peptides  were prepared from either spleen  cells  or tumor  13 
cells using a modification  of the method of Van Bleek  and Nathenson 
(26) as previously described (25). Briefly, cells were lysed at a con- 
centration  of 10  s cells/ml in buffer containing  0.5% NP-40 and  m37 
cleared of nuclei and unlysed cells. K  b or K  bins molecules were 
bound to protein A-Sepharose beads (1 ml packed volume beads 
for 109 cells) to which the Y3 mAb was coupled using 1 mg an- 
tibody/1 ml beads. Lysate and beads were incubated for 1 h at 4~ 
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Table  1.  Lysis  of B6 and bin8 Targets by H-2KS-specific 
CTL Clones 
Percent specific 
lysis  ~ 
Effector/target ratio  bin8  B6 
10  4  100 
1  4  100 
10  0  98 
1  0  78 
10  0  98 
1  0  87 
10  0  49 
1  0  13 
10  0  60 
1  0  8 
10  38  37 
1  22  21 
* Targets were Con A blasts prepared from bm8 or B6 spleens. 
MHC-Peptide Complex May Cause Alloreactivity ther bm8 or B6 spleen cells and used in an attempt to recon- 
stitute recognition of "empty" K b molecules expressed  by 
T2-K  b targets by two different Kb-specific CTL clones from 
bm8 responders,  bm8.28 and bm8.10. As demonstrated in 
Fig. 1, a and b, these clones recognized a peptide found in 
both the bm8 and B6 peptide preparations.  However, the 
amount of peptide found in the bm8 peptide pool was "10- 
fold lower than in the K b pool. In this same experiment, we 
also assessed the relative amount of peptide present in the 
K b and bm8 peptide pools for a number of other Kb-specific 
CTL clones. Despite the fact that only one of these clones, 
m37, was capable of recognizing bm8 targets, it was observed 
that the majority of the allopeptides were present in both 
extracts.  Most surprising was the observation that whereas 
clone m6 recognized K b but not bm8,  the peptide recog- 
nized by clone m6 was actually present at a higher concen- 
tration in the pool of peptides released from K bms than from 
K b.  Similar results were obtained using two other peptide 
preparations. Thus, the difference in recognition of bm8 and 
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Figure  1.  Recognition  of allopeptides extracted from K  b and m  bms 
molecules by K  b specific CTL. 2 x  105 Cr-labeled T2-K  b targets were 
incubated in a volume  of 100/A with the indicated  volume  of peptide, 
diluted to 2 ml, and distributed  in microtiter  wells  (100/A/well) that then 
received 10  s effector  cells of the indicated  clone in a volume of 100/zl. 
(I) Lysis  of T2-K  b in the absence of added peptide. (O) Lysis  of T2-K  b 
in the presence of peptide extracted  from K  b. (O) Lysis of T2-K  b in the 
presence of peptide extracted from K  broS. 
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B6  targets was not solely attributable to the amount of a 
specific allopeptide. 
In general, alloreactive  clones are usually highly specific 
in that they recognize a unique peptide or set  of peptides 
presented by the MHC molecule (13-16).  However, it was 
possible that different peptide species present in the K b and 
K bin8 extracts were being recognized by the various T  cell 
clones.  To determine if the same peptide species in each of 
these complex peptide pools was responsible for allorecogni- 
tion, peptide extracts were resolved by HPLC and individual 
fractions tested for their ability to promote lysis of T2-K  b 
targets. As demonstrated by the experimental results in Fig. 
2, the dominant peaks of activity present in the K b and K bins 
extracts recognized by three of the clones  analyzed by this 
procedure (bm8.28, m37, and m6) migrated at the same po- 
sition on HPLC, strongly suggesting that the same peptide 
was present in both extracts. Of interest, the major peaks 
of activity responsible  for recognition by bm8.10 migrated 
at different positions in the K b and K bms extracts. This sug- 
gests that for this particular clone,  different peptide species 
were responsible  for the lysis observed in the experiment de- 
scribed in Fig. 1, which utilized unfractionated pools of pep- 
tides.  However, the fact that the position representing the 
major peak of activity in the one extract also represented a 
minor peak in the other extract suggests that both peaks were 
present in both extracts and that this, again, was a quantita- 
tive difference in the amount of binding to each molecule. 
Considering that the concentration of the allopeptide rec- 
ognized by bm8.28 was significantly lower in the pool of 
peptides extracted from K bms than K b, it was possible  that 
the reason bm8.28 was unable to lyse bm8 targets was the 
low level of presentation of this allopeptide. If this were the 
case, then it should be possible to obtain lysis ofbm8 targets 
by providing a sufficiently  high concentration of the relevant 
allopeptide to the K bm8 molecule. 
Also,  considering empty class I molecules such as those 
expressed  on the processing deficient cell line T2 (29,  30) 
are far more receptive to exogenous peptide loading than mol- 
ecules on normal cells, T2 cells were transfected with the 
K bms gene in order to obtain a target with empty bm8 mol- 
ecules. The T2-K  bms cells obtained expressed  threefold less 
K bins than the amount of K b expressed  on T2-K  b as deter- 
mined by FACS  |  analysis (data not shown). These cells were 
able to present the VSV-N peptide for recognition by an ap- 
propriate peptide-specific  CTL line. However, as anticipated 
due to their somewhat reduced level of K bin8 relative to K b, 
they required approximately sixfold more VSV-N peptide as 
compared with T2-K  b targets to achieve comparable levels 
of lysis (Fig.  3 b).  In initial experiments, T2-K  bms targets 
were incubated with the HPLC fraction containing the par- 
tially purified bm8.28 allopeptide extracted from K bins mol- 
ecules.  Although  the  peptide  facilitated  lysis  of  T2-K  b 
targets by clone bm8.28, no lysis of peptide pulsed T2-K  bins 
was obtained (data not shown). Since there was 10-fold more 
allopeptide activity present in B6 than bm8, it would be prefer- 
able to use B6 as a source of peptide from which to purify 
large quantities of the bm8.28 allopeptide. To this end, the 
allopeptide was purified from 101~  B6 cells. As demonstrated 0.00 
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Figure  2.  HPLC  purification  of the  allopeptides  recognized  by  K b 
specific CTL clones eluted from K b and K bins molecules. Peptides eluted 
from the indicated source were fractionated by HPLC  as previously de- 
scribed (25). The indicated CTL clones were used to assay K b fractions 
(O) or bm8 fractions (O) incubated with T2-K b target cells at an effector 
to target ratio of 10:1. Lysis of EL4 targets (I-7) served as a positive control 
and lysis of T2-K b in the absence of peptide  (m)  served as a  negative 
control. 
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Figure  3.  Recognition of T2-K bms by VSV-N specific  CTL and clone 
bm8.28. The allopeptide recognized by bm8.28 is HPLC fraction 31 ob- 
tained from EL4 tumor cells as described in ref. 25. The indicated volume 
of fraction 31  (a) or amount of VSV-N peptide (b) was incubated with 
either T2-K b (Q) or T2-K bms (O) targets as described in Fig.  1 and cells 
were used as targets for the indicated CTL. 
in Fig. 3 a, as little as 0.3 #1 of this peptide preparation was 
sufficient  to  detect lysis  of T2-K  b targets by the bm8.28 
CTL clone.  In contrast, we were unable to obtain lysis of 
T2-K  bins targets using as much as  100-fold more peptide. 
Since we could not obtain lysis by clone bm8.28 of T2- 
K bins cells, we wished to ascertain that these targets were in- 
deed binding the relevant  allopeptide.  T2-K  bms cells were 
first incubated with the HPLC fraction that contained the 
bm8.28 allopeptide, cells were washed, and the K bin8 mole- 
cules purified for the purpose of reextracting bound peptide. 
This same procedure was followed using T2-K  b cells, and 
the peptides extracted from each were incubated with T2-K  b 
targets. As demonstrated in Fig. 4 a, the amount of allopep- 
tide that was bound by T2-K  bm8 was only about 6-10-fold 
less than  the  amount that had bound T2-K  b.  Thus,  the 
amount of peptide bound by T2-K  bms targets should have 
been sufficient  to obtain lysis had the bm8.28  clone been 
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Figure  4.  Reextraction of peptides from T2-K bins cells.  20 #1 of the 
HPLC fraction containing the allopeptide recognized by bm8.28 (a) or 
0.1 #g of the VSV-N peptide (b) was incubated with  107 T2-K bms (O) 
or T2-K b (O) cells for 3 h  at 37~  Peptides were extracted from K b or 
K bins molecules as described under Materials and Methods and dissolved 
in 100 #I of PBS. The indicated volume of reextracted peptide was added 
to slCr-labeled T2-K  b targets and detected using either bm8.28 (E/T ratio 
20:1) or VSV-N-specific CTL (E/T ratio 10:1) in a 6-h SlCr-release assay. 
Lysis of T2-K b in the absence of peptide (m) served as a negative control. 
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When  this  same protocol was followed using  the VSV-N 
peptide, it was found that 10-30-fold less peptide bound T2- 
bin8 than  T2-K  b (Fig.  4 b).  Considering  that both targets 
are recognized by VSV-N-specific CTL, this again suggests 
that there should have been adequate amounts of the bm8.28 
allopeptide  to achieve  recognition  and lysis. 
Discussion 
There is now ample evidence that the majority of alloreac- 
tive CTL are as peptide-specific in their recognition of class 
I as conventional antigen-specific CTL (reviewed in 13). The 
heterogeneity of peptides that bind a single class I molecule 
can readily explain the high frequency and receptor diversity 
of an alloresponse.  The basis for the antigenicity of these com- 
plexes is the subject of this investigation. The naturally arising 
K b mutants  always involve one or more  amino  acids  that 
affect peptide binding. The bm8 mutant is particularly  striking 
in this regard,  since its mutations  are confined exclusively 
to residues involved in peptide binding as opposed to the pos- 
sibility of direct interaction with the TCR (residues 22, 23, 
24, and 30). In particular,  residue 24 is most involved in de- 
termining the bm8 phenotype as defined by both allorecog- 
nition  and peptide binding  (21,  22).  In contrast,  many of 
the other K b mutants  are altered not only in residues that 
affect peptide binding,  but also in residues that  could alter 
interactions  with the TCR (18).  Unlike these other natur- 
ally arising K b mutants, the only way the bm8 mutant could 
stimulate K b responders would be through its effect on pep- 
tide binding as opposed to an effect on portions of the MHC 
that interact with the TCR.  Indeed, in a recent analysis  of 
the  endogenous  peptides  bound  by K b and  K bins,  it  was 
found that significant differences in the HPI_C profile of bound 
peptides was apparent  (20).  Our goal in this  study was to 
learn more about the contribution of such peptide differences 
to this alloresponse. In particular, was it due to the quantita- 
tive or qualitative differences in the peptides bound by these 
molecules, or alternatively, to conformational differences in 
the appearance of the peptide-MHC complex as viewed by 
the TCR? 
Our results suggest that the most frequently observed differ- 
ence in the ability of K b and K bins to bind peptide is quan- 
titative rather than qualitative. In most cases in which a par- 
ticular allopeptide is sought,  it can be found on both K bms 
and K b. This is similar to what has also been observed for 
the binding of K b restricted minor antigens,  which are not 
recognized in association with bm8, yet are found in mix- 
tures of peptides extracted from bin8, albeit at reduced level 
(31).  It is important  to note,  this reduced level of binding 
does not necessarily account for lack of recognition in associ- 
ation with bin8. For example, the VSV-N peptide is recog- 
nized when presented by either K b or K bms, yet it binds K bms 
at least 10-fold less well. A dramatic example of a situation 
in which the amount of peptide bound does not predict T 
cell recognition is exhibited by the alloreactive clone,  m6. 
This  clone  recognizes  K b but  not  bm8  targets,  yet  the 
amount of peptide that can be extracted from K b expressing 
cells is much less than from K bms expressing cells. Taken to- 
gether, these results suggest that although many peptides that 
bind K b are reduced in their ability to bind K bins, this is not 
necessarily the reason for lack of recognition.  It appears the 
number of peptide molecules bound per cell is usually more 
than  adequate for T  cell recognition,  when the target  ex- 
presses wild type KL  Rather,  it is the fact that  bm8-pep- 
tide complex is not recognized by the TCR.  Considering 
that  there can be no sequence differences in either the pep- 
tide or MHC that can explain such lack of interaction with 
the TCR, it must be concluded this is due to conformation 
differences that are indirectly attributable to the bm8 mutation. 
In  a  recent  report,  Chen  et  al.  (19)  demonstrated  the 
significance of conformational alteration of a peptide-MHC 
complex to recognition by OVA-specific CTL. In this study 
it was found that by changing a residue in the peptide that 
interacted with pocket B on K b it was possible to eliminate 
recognition by OVA-specific CTL. Our results demonstrate 
that alteration in the MHC can have a similar conformational 
effect leading to ablation of T cell recognition. We have fur- 
ther demonstrated that such a conformational alteration can 
be responsible for the  stimulation  of alloreactive T  cells. 
There have been several reports concerning the possibility 
that conformational changes in the MHC per se could lead 
to allorecognition  (32-34).  It has  been observed that  high 
concentrations of synthetic peptide could restore recognition 
of empty class I by some allospecific CTL, thereby suggesting 
specific peptide was not required for recognition, but rather 
the conformation of the MHC molecule induced by peptide 
(34).  Considering  that the number of MHC-peptide com- 
plexes required to achieve  such cross-reactive recognition is 
much higher than occurs normally for most endogenously 
derived self-peptides, it is not yet known to what extent this 
type of mechanism may contribute to normal alloresponses. 
The affinity required for cross-reactive recognition is likely 
to much lower than the affinity required for initial stimula- 
tion  of a T  cell. 
Our results do not  allow us to distinguish  whether  the 
conformational difference responsible for loss of T cell receptor 
recognition of K bins is exhibited by the peptide, the MHC, 
or both. In view of the fact that the conformational epitopes 
described in this report are dependent on the presence of a 
specific allopeptide,  and that it is unlikely the K bm8 and K b 
molecules differ conformationally in their ol-helical regions, 
it seems most likely the relevant conformational differences 
involve the peptide. Further understanding of the structural 
consequences of the bm8 mutation  and how it  effects  the 
conformation of a particular peptide-MHC complex awaits 
x-ray crystallographic  information. 
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